1. Ten years’ experience with benzbromarone in the management of gout and hyperuricaemia;Masbernard;S Afr Med J,1981
2. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?;Lee;Drug Saf,2008
3. Hepatic injury caused by benzbromazone;van der Klauw;J Hepatol,1994
4. Hépatite à la benzarone: un deuxième cas;Nakad;Gastroentérol Clin Biol,1990
5. Hépatite medicamenteuse liée à la benzarone (Fragivix®): à propos d’une observation clinique;Sepulchre;Acta Gastroenterol Belg,1990